Diagnosing by probe where cardiac arrhythmias occur

Hinweis zur Verwendung von Bildmaterial: Die Verwendung des Bildmaterials zur Pressemitteilung ist bei Nennung der Quelle vergütungsfrei gestattet. Das Bildmaterial darf nur in Zusammenhang mit dem Inhalt dieser Pressemitteilung verwendet werden. Falls Sie das Bild in höherer Auflösung benötigen oder Rückfragen zur Weiterverwendung haben, wenden Sie sich bitte direkt an die Pressestelle, die es veröffentlicht hat.
The Jena Leibniz Institute of Photonic Technology (Leibniz IPHT) is coordinating a european research team to develop a multimodal imaging fiber probe that can diagnose critical sites for the development of cardiac arrhythmias.
Cardiac arrhythmias are considered to be one of the main causes of sudden cardiac death. In the „Multimodal Fiber Optic Probe for Highly Resolved in Vivo Localization of Cardiac Fibrosis“ (MultiFib) project, the Jena research team is working with partners from the Medical University of Vienna and the Institute for Rhythmology and Cardiac Modeling (Liryc) in Bordeaux, which specializes in the research and treatment of cardiac arrhythmias. „We want to develop catheters that can be used where the arrhythmia occurs,“ explains project leader Iwan Schie from Leibniz IPHT. „At the same time, they will be able to monitor in real time during the operation whether ablation therapy in which these critical sites are sclerosed is successful. The European Commission is funding MultiFib under the ERA-NET programme in Horizon 2020 until April 2021.
Wissenschaftlicher Ansprechpartner:
Dr. Iwan Schie
Leibniz Institute of Photonic Technology (Leibniz IPHT)
+49 (0) 3641 206-313 // iwan.schie(a)leibniz-ipht.de
Weitere Informationen: